ResearcherUniversity of PittsburghNo recent work listed
Andrew J. Lee
Matched on ORCID iD 0000-0003-4224-978X; OpenAlex author ID A5100450505. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2019: 2 papers · 2020: none · 2021: 1 paper
Papers 3
- Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. First author DOI 10.1245/s10434-020-09518-y↗
- Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. Co-author DOI 10.1016/j.hpb.2019.01.011↗
- Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. First author DOI 10.1016/j.jss.2019.04.090↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthew H. G. Katz · 3 shared papers, 2019–2021 · strength 0.31
- Paper Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic… DOI 10.1245/s10434-020-09518-y↗
- Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗
- Paper Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. DOI 10.1016/j.jss.2019.04.090↗
- Michael P. Kim · 3 shared papers, 2019–2021 · strength 0.31
- Paper Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic… DOI 10.1245/s10434-020-09518-y↗
- Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗
- Paper Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. DOI 10.1016/j.jss.2019.04.090↗
- Jeffrey E. Lee · 3 shared papers, 2019–2021 · strength 0.31
- Paper Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic… DOI 10.1245/s10434-020-09518-y↗
- Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗
- Paper Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. DOI 10.1016/j.jss.2019.04.090↗
- Ching-Wei David Tzeng · 3 shared papers, 2019–2021 · strength 0.31
- Paper Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic… DOI 10.1245/s10434-020-09518-y↗
- Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗
- Paper Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. DOI 10.1016/j.jss.2019.04.090↗
- Diego A. Vicente · 2 shared papers, 2019–2021 · strength 0.22
- Michael Geoffrey White · 1 shared paper, 2021 · strength 0.13
- Naruhiko Ikoma · 1 shared paper, 2021 · strength 0.13
- Ève Simoneau · 1 shared paper, 2019 · strength 0.10
- Jean‐Nicolas Vauthey · 1 shared paper, 2019 · strength 0.10
- Andrew D. Rhim · 1 shared paper, 2019 · strength 0.09
- Anirban Maitra · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.